Tag:
Oncoscience
Latest Headlines
Latest Headlines
YM withdraws European app for nimotuzumab
YM BioSciences's European partner Oncoscience has withdrawn its EMEA application for marketing authorization of nimotuzumab, an oncology drug already approved in 12 countries. In its official letter
